GE HealthCare Technologies GEHC PCS — D&A

Other segment segments

Similar metrics at other companies

LYBAPS — D&A

$20M0.0%

IPPS NA — D&A

$230M-44.3%

LHXCS — D&A

$18M+5.9%

CBTPerformance Chemicals — D&A

$21M+7.7%

CAHPharmaceutical and Specialty Solutions — D&A

$70M+59.1%

CMIPower Systems — D&A

$36M+9.1%

Questions, answered.

What is GE HealthCare Technologies's PCS — D&A?

GE HealthCare Technologies (GEHC) reported PCS — D&A of $13M in Q1 2026.

How has GE HealthCare Technologies's PCS — D&A changed year-over-year?

GE HealthCare Technologies's PCS — D&A decreased by 0.0% year-over-year, from $13M to $13M.

What is the long-term trend for GE HealthCare Technologies's PCS — D&A?

Over 3 years (2022 to 2025), GE HealthCare Technologies's PCS — D&A has grown at a -10.7% compound annual growth rate (CAGR), from $73M to $52M.

What does PCS — D&A mean?

The non-cash expense allocated to the Patient Care Solutions segment representing the systematic write-down of tangible assets and intangible assets over their useful lives. This reflects the capital intensity of the segment's manufacturing and R&D operations.